Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Timber Pharmaceuticals Inc (NY: TMBR )

3.080 -0.030 (-0.96%)
Streaming Delayed Price Updated: 9:30 AM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 628
Open 3.080
Bid (Size) 3.060 (4)
Ask (Size) 3.090 (1)
Prev. Close 3.110
Today's Range 3.080 - 3.080
52wk Range 0.0610 - 3.390
Shares Outstanding 3,086,489
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+30.51%
+30.51%
1 Month
+3.01%
+3.01%
3 Month
+56.35%
+56.35%
6 Month
+50.98%
+50.98%
1 Year
+2884.50%
+2884.50%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
Why Timber Pharmaceuticals Stock Is Skyrocketing Today
Via Benzinga
Crude Oil Falls; Nikola Shares Plummet
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Dow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Is Skillz (SKLZ) Stock Up 20% Today?
Via InvestorPlace
Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?
Via InvestorPlace
US Stocks Mostly Higher; Nasdaq Jumps 100 Points
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Timber Pharmaceuticals to be Acquired by LEO Pharma
Via NewMediaWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Timber Pharmaceuticals Discloses Communication From NYSE American
Via NewMediaWire
Timber Pharmaceuticals to Present Interim Analyses from Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis
Via NewMediaWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Dow Drops Over 100 Points; Crude Oil Rises
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Nasdaq Rises 70 Points; ISM Services PMI Drops In May
Via Benzinga
Timber Pharmaceuticals’ (NYSE American: TMBR) Phase 3 ASCEND Study for TMB-001: A Leap Forward in Congenital Ichthyosis Treatment
Via Spotlight Growth
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.